REGULATED INFORMATION
Nyxoah Reports Second Quarter and First Half 2022 Financial and Operating Results
DREAM enrollment complete, 12-month clinical data expected in fall of 2023
Read more at globenewswire.comAll information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here
This article could contain syndicated content. We have not reviewed, approved, or endorsed the content and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here
REGULATED INFORMATION
Nyxoah Reports Second Quarter and First Half 2022 Financial and Operating Results
DREAM enrollment complete, 12-month clinical data expected in fall of 2023
Read more at globenewswire.comSymbol | Last | Chg | %Chg |
---|---|---|---|
NYXH | 7.72 | -0.03 | -0.39% |
Nyxoah S A |